Evidence map›Paper›PMID 38476717›Full record

ArticleDental research journal2024

Anti-cancer effects of green synthesized gold nanoparticles using leaf extract of

S Jeslin Mary, Veeran Veeravarmal, Prasanth Thankappan, Paramasivam Arumugam, Percy Ida Augustine, R Franklin

Open access · goldAbstract read
In one paragraph

Article in Dental research journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
6.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Bio-Inspired Synthesis of Gold Nanoparticles Using Leaf Extract ofInternational journal of nanomedicine · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

S Jeslin MaryDepartment of Oral and Maxillofacial Pathology, Sree Mookambika Institute of Dental Sciences, Kanyakumari, Tamil Nadu, India.
Veeran VeeravarmalDepartment of Oral and Maxillofacial Pathology, Government Dental College, Cuddalore, Tamil Nadu, India.
Prasanth ThankappanDepartment of Oral and Maxillofacial Pathology, Sree Mookambika Institute of Dental Sciences, Kanyakumari, Tamil Nadu, India.
Paramasivam ArumugamCenter for Cellular and Molecular Research, Saveetha Dental College and Hospital, Saveetha University, Chennai, Tamil Nadu, India.
Percy Ida AugustineConsultant, Oral and Maxillofacial Pathologist, Joannas Dental Care, Tamil Nadu, India.
R FranklinDepartment of Oral and Maxillofacial Pathology, Sree Mookambika Institute of Dental Sciences, Kanyakumari, Tamil Nadu, India.
Kamineni Institute of Dental Sciences · INGovernment Dental College and Hospital · INSaveetha University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Oral cancer remains one of the most dreadful diseases in developing nations. Currently, there has been a rise in the prevalence of tongue squamous cell carcinoma (SCC), with a poor prognosis. The use of standard treatment approaches against oral cancer patients brings about several side effects. In recent years, nanomedicine has provided a versatile platform for developing new targeted therapeutic modalities. However, safety remains a concern in the synthesis of nanoparticles (NPs). Therefore, the present study aims to synthesize safer phytoconstituent-mediated gold NPs (AuNPs) utilizing leaf extracts of Materials and Methods: In this Results: The Conclusion: Our findings demonstrated that the AuNPs synthesized from

Indexed as

Anticancer agentapoptosisnanoparticlesoral tongue squamous cell carcinoma

Identifiers

PMID38476717
PMCPMC10929727
OpenAlexW4392015407

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.